Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation: a …

WCY Lau, CL Cheung, KKC Man, EW Chan… - Annals of internal …, 2020 - acpjournals.org
Background: It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …
被引用次数：68 相关文章

Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A …

WCY Lau, CL Cheung, KKC Man, EW Chan… - Annals of Internal …, 2020 - europepmc.org
BACKGROUND: It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …

Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A …

CY Lau, CL Cheung, KKC Man, EW Chan… - Annals of Internal …, 2020 - hub.hku.hk
Background: It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …

Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A …

WCY Lau, CL Cheung, KKC Man, EW Chan… - Annals of Internal …, 2020 - vbn.aau.dk
BACKGROUND: It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …

Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and the risk of osteoporotic fractures among patients with atrial fibrillation: A …

WCY Lau, CL Cheung, K Man, EW Chan… - Annals of Internal …, 2020 - discovery.ucl.ac.uk
Background: It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …

Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A …

WCY Lau, CL Cheung, KKC Man… - Annals of internal …, 2020 - pubmed.ncbi.nlm.nih.gov
Background It is unclear whether anticoagulant type is associated with the risk for
osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial …

[引用][C] Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation

WCY Lau, CL Cheung, KKC Man, EW Chan… - Annals of Internal …, 2020 - cir.nii.ac.jp
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk
for Osteoporotic Fractures Among Patients With Atrial Fibrillation | CiNii Research CiNii 国立 …